MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1014.31%
Quick Ratio
1014.31%
Cash Ratio
152.40%
Debt to Asset Ratio
19.85%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Long-term investments
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities, net...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
13,166
14,626
12,388
23,875
Short-term investments
70,865
81,243
91,018
107,552
Prepaid expenses and other current assets
3,595
2,963
2,557
2,898
Total current assets
87,626
98,832
105,963
134,325
Property and equipment, net
3,999
3,635
3,457
3,624
Operating lease right-of-use assets
25,619
26,631
27,773
24,727
Long-term investments
45,155
47,505
52,739
37,059
Other long-term assets
1,177
1,176
1,180
1,180
Total assets
163,576
177,779
191,112
200,915
Accounts payable
1,095
1,186
943
893
Accrued expenses and other liabilities
3,553
3,305
3,177
3,880
Current portion of operating lease liabilities
3,991
3,852
3,832
4,209
Total current liabilities
8,639
8,343
7,952
8,982
Operating lease liabilities, net of current portion
23,825
25,021
26,187
22,794
Total liabilities
32,464
33,364
34,139
31,776
Common stock, 0.0001 par value, 1,000,000,000 shares authorized as of june30, 2026 and december31, 2025 127,224,640 and 126,469,610 shares issued and outstanding as of june30, 2026 and december31, 2025, respectively
13
13
13
13
Additional paid-in capital
492,616
491,210
488,737
487,165
Accumulated other comprehensive income (loss)
-331
-91
243
200
Accumulated deficit
-361,186
-346,717
-332,020
-318,239
Total stockholders equity
131,112
144,415
156,973
169,139
Total liabilities and stockholders equity
163,576
177,779
191,112
200,915
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$70,865K (-37.52%↓ Y/Y)Cash and cashequivalents$13,166K (-61.79%↓ Y/Y)Prepaid expenses andother current assets$3,595K (26.05%↑ Y/Y)Total current assets$87,626K (-41.86%↓ Y/Y)Long-term investments$45,155K (42.73%↑ Y/Y)Operating leaseright-of-use assets$25,619K (-1.16%↓ Y/Y)Property and equipment,net$3,999K (7.27%↑ Y/Y)Other long-termassets$1,177K (-0.25%↓ Y/Y)Total assets$163,576K (-23.27%↓ Y/Y)Total liabilities andstockholders equity$163,576K (-23.27%↓ Y/Y)Total stockholdersequity$131,112K (-27.60%↓ Y/Y)Total liabilities$32,464K (1.15%↑ Y/Y)Accumulated deficit-$361,186K (-18.55%↓ Y/Y)Accumulated othercomprehensive income (loss)-$331K (-529.87%↓ Y/Y)Additional paid-in capital$492,616K (1.43%↑ Y/Y)Operating leaseliabilities, net of current...$23,825K (-0.56%↓ Y/Y)Total currentliabilities$8,639K (6.17%↑ Y/Y)Common stock, 0.0001par value,...$13K (0.00%↑ Y/Y)Current portion ofoperating lease...$3,991K (-5.54%↓ Y/Y)Accrued expenses andother liabilities$3,553K (20.93%↑ Y/Y)Accounts payable$1,095K (12.42%↑ Y/Y)

Nautilus Biotechnology, Inc. (NAUT)

Nautilus Biotechnology, Inc. (NAUT)